AEHR PE Ratio & Valuation,Is AEHR Overvalued

AEHR Relative Valuation

AEHR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, AEHR is overvalued; if below, it's undervalued.

Historical Valuation

Aehr Test Systems (AEHR) is now in the Overvalued zone, suggesting that its current forward PE ratio of 174.93 is considered Overvalued compared with the five-year average of 48.61. The fair price of Aehr Test Systems (AEHR) is between 1.69 to 12.27 according to relative valuation methord. Compared to the current price of 24.48 USD , Aehr Test Systems is Overvalued By 99.56%.

Relative Value

Fair Zone

1.69-12.27

Current Price：24.48

99.56%

Overvalued

174.93

0.00

EV/EBITDA

Aehr Test Systems. (AEHR) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 8.62. The thresholds are as follows: Strongly Undervalued below -23.51, Undervalued between -23.51 and -7.44, Fairly Valued between 24.69 and -7.44, Overvalued between 24.69 and 40.75, and Strongly Overvalued above 40.75. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-2936.86

EV/EBIT

Aehr Test Systems. (AEHR) has a current EV/EBIT of -2936.86. The 5-year average EV/EBIT is -99.76. The thresholds are as follows: Strongly Undervalued below -1352.15, Undervalued between -1352.15 and -725.95, Fairly Valued between 526.44 and -725.95, Overvalued between 526.44 and 1152.64, and Strongly Overvalued above 1152.64. The current Forward EV/EBIT of -2936.86 falls within the Strongly Undervalued range.

11.26

Aehr Test Systems. (AEHR) has a current PS of 11.26. The 5-year average PS is 7.14. The thresholds are as follows: Strongly Undervalued below -1.47, Undervalued between -1.47 and 2.83, Fairly Valued between 11.45 and 2.83, Overvalued between 11.45 and 15.75, and Strongly Overvalued above 15.75. The current Forward PS of 11.26 falls within the Historic Trend Line -Fairly Valued range.

46.91

P/OCF

Aehr Test Systems. (AEHR) has a current P/OCF of 46.91. The 5-year average P/OCF is 19.50. The thresholds are as follows: Strongly Undervalued below -35.94, Undervalued between -35.94 and -8.22, Fairly Valued between 47.23 and -8.22, Overvalued between 47.23 and 74.95, and Strongly Overvalued above 74.95. The current Forward P/OCF of 46.91 falls within the Historic Trend Line -Fairly Valued range.

163.82

P/FCF

Aehr Test Systems. (AEHR) has a current P/FCF of 163.82. The 5-year average P/FCF is 32.39. The thresholds are as follows: Strongly Undervalued below -74.22, Undervalued between -74.22 and -20.91, Fairly Valued between 85.70 and -20.91, Overvalued between 85.70 and 139.00, and Strongly Overvalued above 139.00. The current Forward P/FCF of 163.82 falls within the Strongly Overvalued range.

Aehr Test Systems (AEHR) has a current Price-to-Book (P/B) ratio of 6.00. Compared to its 3-year average P/B ratio of 7.39 , the current P/B ratio is approximately -18.81% higher. Relative to its 5-year average P/B ratio of 8.54, the current P/B ratio is about -29.81% higher. Aehr Test Systems (AEHR) has a Forward Free Cash Flow (FCF) yield of approximately -2.21%. Compared to its 3-year average FCF yield of -0.30%, the current FCF yield is approximately 639.11% lower. Relative to its 5-year average FCF yield of -0.88% , the current FCF yield is about 150.98% lower.

6.00

P/B

Median3y

7.39

Median5y

8.54

-2.21

FCF Yield

Median3y

-0.30

Median5y

-0.88

Competitors Valuation Multiple

The average P/S ratio for AEHR's competitors is 5.57, providing a benchmark for relative valuation. Aehr Test Systems Corp (AEHR) exhibits a P/S ratio of 11.26, which is 102.35% above the industry average. Given its robust revenue growth of -16.39%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

Performance Decomposition

Market capitalization of AEHR increased by 47.20% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -17.09 to -109.62.

The secondary factor is the Revenue Growth, contributed -16.39%to the performance.

Overall, the performance of AEHR in the past 1 year is driven by P/E Change. Which is more unsustainable.

-16.39%

13.12M → 10.97M

Revenue Growth

-477.73%

5.03 → -19.00

Margin Expansion

541.32%

-17.09 → -109.62

P/E Change

47.20%

16.63 → 24.48

Mkt Cap Growth

People Also Watch

Frequently Asked Questions

Is Aehr Test Systems (AEHR) currently overvalued or undervalued?

What is Aehr Test Systems (AEHR) fair value?

AEHR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Aehr Test Systems (AEHR) is between 1.69 to 12.27 according to relative valuation methord.

How does AEHR's valuation metrics compare to the industry average?

What is the current P/B ratio for Aehr Test Systems (AEHR) as of Dec 15 2025?

As of Dec 15 2025, Aehr Test Systems (AEHR) has a P/B ratio of 6.00. This indicates that the market values AEHR at 6.00 times its book value.

What is the current FCF Yield for Aehr Test Systems (AEHR) as of Dec 15 2025?

As of Dec 15 2025, Aehr Test Systems (AEHR) has a FCF Yield of -2.21%. This means that for every dollar of Aehr Test Systems’s market capitalization, the company generates -2.21 cents in free cash flow.

What is the current Forward P/E ratio for Aehr Test Systems (AEHR) as of Dec 15 2025?

As of Dec 15 2025, Aehr Test Systems (AEHR) has a Forward P/E ratio of 174.93. This means the market is willing to pay $174.93 for every dollar of Aehr Test Systems’s expected earnings over the next 12 months.

What is the current Forward P/S ratio for Aehr Test Systems (AEHR) as of Dec 15 2025?

As of Dec 15 2025, Aehr Test Systems (AEHR) has a Forward P/S ratio of 11.26. This means the market is valuing AEHR at $11.26 for every dollar of expected revenue over the next 12 months.

AEHR Valuation